Bausch Health US., LLC. FDA Inspection Record
Bausch Health US., LLC. is an FDA-inspected facility (FEI 3010446985) located in Bridgewater, NJ, US. RegDataLab tracks 8 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Nov 7, 2024: Voluntary Action Indicated (VAI)
- Inspections on record
- 8 (3 VAI, 5 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 19, latest Feb 2, 2024
- Import refusals
- 6
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Nov 7, 2024 | Voluntary Action Indicated (VAI) | Failure to comply with REMS Implementation System (FDCA 505-1(f)(4)) |
| Apr 18, 2024 | No Action Indicated (NAI) | No citations listed |
| Jun 16, 2021 | Voluntary Action Indicated (VAI) | Failure to comply with REMS Implementation System (FDCA 505-1(f)(4)) |
| May 16, 2019 | No Action Indicated (NAI) | No citations listed |
| Feb 28, 2018 | No Action Indicated (NAI) | No citations listed |
| May 17, 2016 | No Action Indicated (NAI) | Late submission of 15-day report (21 CFR 314.80(c)(1)(i)) Failure to maintain records (21 CFR 314.80(j)) |
| May 19, 2014 | Voluntary Action Indicated (VAI) | Sponsors' general responsibilities (21 CFR 812.40) Sponsor device shipment records inadequate (21 CFR 812.140(b)(2)) Other sponsor records required by FDA inadequate (21 CFR 812.140(b)(6)) No financial disclosure info in investigator agreement (21 CFR 812.43(c)(5)) and 3 more |
| Dec 24, 2013 | No Action Indicated (NAI) | No citations listed |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Feb 2, 2024 | Class II | D-0355-2024 | Omeprazole and Sodium Bicarbonate For Oral Suspension
40mg/1,680mg, This packet contains… Subpotent Drug: Out of specification for assay |
| Jun 8, 2021 | Class III | D-0638-2021 | Mephyton (Phytonadione) 5 mg tablets, 100-count tablets, Rx Only, Manufactured for… and 1 more product Failed Impurities/Degradation Specifications |
| Jan 7, 2021 | Class III | D-0243-2021 | Mephyton (phytonadione) Tablets 5mg, 100-count bottle, Rx Only, Manufactured for: Valeant… and 1 more product Failed Impurities/Degradation Specifications:Out of specification during the 24 month stability testing of Impurity D. |
| Jul 13, 2020 | Class II | D-0054-2021 | Hydrocortisone butyrate Cream, 0.1%, 15-gram tubes, Rx Only, Manufactured for Oceanside… SUBPOTENT DRUG |
| Jan 30, 2019 | Class III | D-0487-2019 | Cardizem CD (diltiazem HCl) capsules, 120 mg, packaged in a) 30-count bottles (NDC… and 4 more products Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain… |
| Aug 24, 2018 | Class II | D-0084-2019 | Cortaid Intensive Therapy Cooling Spray (1% hydrocortisone), 2 FL OZ (59 mL) spray bottle… and 2 more products CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility… |
| Jul 10, 2018 | Class III | D-1041-2018 | Diazepam Rectal Gel, 2.5 mg, TWIN PACK that Contains two pre-filled, unit-dose, rectal… Labeling: Incorrect or Missing Lot and/or Exp Date: Product distributed without a lot number or expiration date on the outer carton. |
| Jun 28, 2017 | Class III | D-0998-2017 | Obagi-C Rx System C-Therapy Night Cream, Net wt. 2 oz. (57g) bottle, Rx only, Distributed… Labeling: Incorrect or Missing Package Insert - Obagi-C Rx System C-Therapy Night Cream is being recalled due to incomplete… |
| Mar 20, 2017 | Class III | D-0672-2017 | CLENZIderm M.D. Pore Therapy Salicylic Acid 2% Acne Treatment 5 fl. oz. (148 mL), Valeant… and 1 more product Discoloration. |
| Jun 10, 2016 | Class III | D-1059-2016 | SECONAL SODIUM (secobarbital sodium) Capsules, USP, 100 mg, 100 Ct. Bottles, Rx Only… Labeling: Incorrect or Missing Package Insert: Package insert is missing warning regarding anaphylaxis. |
FDA record score
10 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
10 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Nov 7, 2024 | 6 x 0.6 | 3.6 |
| Class II recall D-0355-2024, this FEI as the recalling firm | Feb 2, 2024 | 4 x 0.6 | 2.4 |
| Inspection classified VAI | Jun 16, 2021 | 6 x 0.25 | 1.5 |
| Class II recall D-0054-2021, this FEI as the recalling firm | Jul 13, 2020 | 4 x 0.25 | 1 |
| Class II recall D-0084-2019, this FEI as the recalling firm | Aug 24, 2018 | 4 x 0.25 | 1 |
| Class II recall Z-0371-2016, this FEI as the recalling firm | Sep 14, 2015 | 10 years or older, so it adds no points | 0 |
| Class II recall D-0163-2016, this FEI as the recalling firm | Sep 4, 2015 | 10 years or older, so it adds no points | 0 |
| Class II recall D-1116-2015, this FEI as the recalling firm | Apr 17, 2015 | 10 years or older, so it adds no points | 0 |
| Class II recall D-0379-2015, this FEI as the recalling firm | Dec 31, 2014 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | May 19, 2014 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Bausch Health US., LLC. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Bausch Health US., LLC. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Bausch Health US., LLC.
- Location
- Bridgewater, NJ (US)
- Source
- inspections